- Home
- BCLI vs CLWT Comparison
BCLI vs CLWT Comparison
Compare BCLI & CLWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- CLWT
- Stock Information
- Founded
- BCLI 2000
- CLWT 1971
- Country
- BCLI United States
- CLWT Hong Kong
- Employees
- BCLI N/A
- CLWT N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- CLWT Professional and commerical equipment
- Sector
- BCLI Health Care
- CLWT Consumer Discretionary
- Exchange
- BCLI Nasdaq
- CLWT Nasdaq
- Market Cap
- BCLI 7.7M
- CLWT 8.9M
- IPO Year
- BCLI N/A
- CLWT 1997
- Fundamental
- Price
- BCLI $1.22
- CLWT $1.24
- Analyst Decision
- BCLI Strong Buy
- CLWT
- Analyst Count
- BCLI 1
- CLWT 0
- Target Price
- BCLI $30.00
- CLWT N/A
- AVG Volume (30 Days)
- BCLI 3.4M
- CLWT 218.4K
- Earning Date
- BCLI 05-15-2025
- CLWT 04-30-2025
- Dividend Yield
- BCLI N/A
- CLWT 6.50%
- EPS Growth
- BCLI N/A
- CLWT N/A
- EPS
- BCLI N/A
- CLWT 0.10
- Revenue
- BCLI N/A
- CLWT $15,383,000.00
- Revenue This Year
- BCLI N/A
- CLWT N/A
- Revenue Next Year
- BCLI N/A
- CLWT N/A
- P/E Ratio
- BCLI N/A
- CLWT $13.04
- Revenue Growth
- BCLI N/A
- CLWT N/A
- 52 Week Low
- BCLI $0.72
- CLWT $1.01
- 52 Week High
- BCLI $8.09
- CLWT $1.84
- Technical
- Relative Strength Index (RSI)
- BCLI 55.90
- CLWT 56.98
- Support Level
- BCLI $1.05
- CLWT $1.12
- Resistance Level
- BCLI $1.18
- CLWT $1.22
- Average True Range (ATR)
- BCLI 0.14
- CLWT 0.07
- MACD
- BCLI 0.00
- CLWT 0.01
- Stochastic Oscillator
- BCLI 23.91
- CLWT 94.44
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About CLWT Euro Tech Holdings Company Limited
Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.